MetaCap

Protalix BioTherapeutics (DE) Statistics

NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.90-0.16 (-5.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Protalix BioTherapeutics (DE) by the numbers

Protalix BioTherapeutics (DE) has a market capitalization of $244.5 million based on 84.32M shares outstanding. Its trailing P/E ratio is 12.1, and its forward P/E is 4.7. The stock trades 6.6% above its 50-day average and 18.1% above its 200-day average.

Average daily trading volume is 903.48K shares, or about $2.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PLX valuation vs. peer median

PLX compared with the median of 8 peer companies
MetricPLXPeer medianDifference
Market cap$244.52M$253.13M-3%
Avg. volume903.48K1.31M-31%

Peer median across 8 companies: LXEO, AUTL, EDIT, SABS, EIKN, SCTX, OCGN, AGMB.

Valuation

Market cap
$244.52M
Price / sales (latest FY)
4.64

Price and trading

Previous close
3.06
Open
3.02
Day range
2.87 – 3.04
52-week range
1.65 – 3.19
52-week change
+65.71%
Beta
—
Volume
1.23M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
244.52M
Pe
12.08
Forward Pe
4.68
Eps
0.24
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.19
Week52 Low
1.65
Avg Volume
903.48K
Shares Outstanding
84.32M
Ma50
2.72
Ma200
2.45
Earnings Date
Nov 10, 2026
Pct From52w High
-9.09%
Pct From52w Low
75.76%

Related